Inner Mongolia University

Macrophages have both anti-tumor and pro-tumor effects. Time delay is commonly observed in real systems, yet its impact on tumor-macrophage dynamics remains unclear. This paper develops a new tumor-macrophage model with time delay. The model describes the interactions between tumor cells (T), the classically activated macrophages (M1), the alternatively activated macrophages (M2), and the inactive macrophages (M0). The system's solution is computed, and equilibrium stability is analyzed. The existence of Hopf bifurcation is subsequently established. There exists bifurcating periodic solutions near the internal equilibrium, showing tumor cells and macrophages can coexist in the long term, as well as the potential for tumor relapse. Furthermore, the normal form and center manifold theorem are utilized to study the nature of Hopf bifurcation. Sensitivity analysis highlights the effect of parameters on tumor population dynamics. Numerical simulations validate the theory, elaborating the model can serve as a useful tool for tumor system analysis.

Live herpesvirus-vectored vaccines are critical in veterinary medicine, but they can sometimes offer insufficient protection due to suboptimal antigen expression or localization. Encephalomyocarditis virus (EMCV) is a significant zoonotic threat, with VP1 protein as a key immunogen on its capsid. To enhance immunogenicity, we explored the use of recombinant pseudorabies virus (rPRV) as a vaccine vector against EMCV. In silico analysis indicated that fusing VP1 with US9 enhances the formation of a type II transmembrane heterodimer. We constructed six rPRV groups expressing different VP1 variants and found that VP1 fused with US9's C-terminal (US9-VP1) enhances VP1's membrane localization and its incorporation into the PRV envelope, unlike wild-type VP1. Immunogold electron microscopy illustrated that rPRV with deleted US8 and US9, supplemented with US8 regulatory sequence (rΔ89-U9VP1), improved VP1 incorporation into the viral envelope. Post-immunization, only rΔ89-U9VP1 provided 100% protection against EMCV in mice and induced high levels of virus-neutralizing antibodies in piglets. Additionally, rPRV expressing VP1 stimulated robust T-cell responses, as demonstrated by flow cytometry and ELISpot assays. This study introduces rPRV as a potential EMCV vaccine, demonstrating that the selection of the US9 C-terminal domain and US8 regulatory sequence significantly enhances the presentation of heterologous antigens, improving vaccine efficacy.

Niobates are promising all-climate Li+-storage anode material due to their fast charge transport, large specific capacities, and resistance to electrolyte reaction. However, their moderate unit-cell-volume expansion (generally 5%–10%) during Li+ storage causes unsatisfactory long-term cyclability. Here, “zero-strain” NiNb2O6 fibers are explored as a new anode material with comprehensively good electrochemical properties. During Li+ storage, the expansion of electrochemical inactive NiO6 octahedra almost fully offsets the shrinkage of active NbO6 octahedra through reversible O movement. Such superior volume-accommodation capability of the NiO6 layers guarantees the “zero-strain” behavior of NiNb2O6 in a broad temperature range (0.53%//0.51%//0.74% at 25// − 10//60 °C), leading to the excellent cyclability of the NiNb2O6 fibers (92.8%//99.2% // 91.1% capacity retention after 1000//2000//1000 cycles at 10C and 25// − 10//60 °C). This NiNb2O6 material further exhibits a large reversible capacity (300//184//318 mAh g−1 at 0.1C and 25// − 10//60 °C) and outstanding rate performance (10 to 0.5C capacity percentage of 64.3%//50.0%//65.4% at 25// − 10//60 °C). Therefore, the NiNb2O6 fibers are especially suitable for large-capacity, fast-charging, long-life, and all-climate lithium-ion batteries.